IPSEN (IPN.PA) Fundamental Analysis & Valuation

EPA:IPN • FR0010259150

Current stock price

159.4 EUR
-3.1 (-1.91%)
Last:

This IPN.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. IPN.PA Profitability Analysis

1.1 Basic Checks

  • In the past year IPN was profitable.
  • In the past year IPN had a positive cash flow from operations.
  • In the past 5 years IPN has always been profitable.
  • IPN had a positive operating cash flow in each of the past 5 years.
IPN.PA Yearly Net Income VS EBIT VS OCF VS FCFIPN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • IPN has a Return On Assets (6.39%) which is comparable to the rest of the industry.
  • IPN has a Return On Equity (10.23%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 13.93%, IPN is in the better half of the industry, outperforming 74.51% of the companies in the same industry.
Industry RankSector Rank
ROA 6.39%
ROE 10.23%
ROIC 13.93%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPN.PA Yearly ROA, ROE, ROICIPN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • IPN's Profit Margin of 11.29% is in line compared to the rest of the industry. IPN outperforms 49.02% of its industry peers.
  • In the last couple of years the Profit Margin of IPN has declined.
  • IPN's Operating Margin of 24.90% is fine compared to the rest of the industry. IPN outperforms 66.67% of its industry peers.
  • IPN's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 80.89%, IPN belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
  • In the last couple of years the Gross Margin of IPN has remained more or less at the same level.
Industry RankSector Rank
OM 24.9%
PM (TTM) 11.29%
GM 80.89%
OM growth 3Y-3.88%
OM growth 5Y-1.79%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
IPN.PA Yearly Profit, Operating, Gross MarginsIPN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IPN.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IPN is still creating some value.
  • IPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IPN.PA Yearly Shares OutstandingIPN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
IPN.PA Yearly Total Debt VS Total AssetsIPN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 4.50 indicates that IPN is not in any danger for bankruptcy at the moment.
  • IPN's Altman-Z score of 4.50 is fine compared to the rest of the industry. IPN outperforms 60.78% of its industry peers.
  • The Debt to FCF ratio of IPN is 1.17, which is an excellent value as it means it would take IPN, only 1.17 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of IPN (1.17) is better than 90.20% of its industry peers.
  • IPN has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of IPN (0.22) is better than 68.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.17
Altman-Z 4.5
ROIC/WACC1.75
WACC7.98%
IPN.PA Yearly LT Debt VS Equity VS FCFIPN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.96 indicates that IPN should not have too much problems paying its short term obligations.
  • IPN has a Current ratio of 1.96. This is in the better half of the industry: IPN outperforms 72.55% of its industry peers.
  • IPN has a Quick Ratio of 1.79. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
  • IPN's Quick ratio of 1.79 is amongst the best of the industry. IPN outperforms 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.79
IPN.PA Yearly Current Assets VS Current LiabilitesIPN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. IPN.PA Growth Analysis

3.1 Past

  • IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
  • IPN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.79% yearly.
  • The Revenue has grown by 9.92% in the past year. This is quite good.
  • Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%9.65%
Revenue 1Y (TTM)9.92%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%1.83%

3.2 Future

  • IPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.81% yearly.
  • Based on estimates for the next years, IPN will show a small growth in Revenue. The Revenue will grow by 6.47% on average per year.
EPS Next Y9.87%
EPS Next 2Y11.02%
EPS Next 3Y8.3%
EPS Next 5Y6.81%
Revenue Next Year8.57%
Revenue Next 2Y9.28%
Revenue Next 3Y7.98%
Revenue Next 5Y6.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IPN.PA Yearly Revenue VS EstimatesIPN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
IPN.PA Yearly EPS VS EstimatesIPN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. IPN.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.52 indicates a correct valuation of IPN.
  • Based on the Price/Earnings ratio, IPN is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.71, IPN is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 12.59, the valuation of IPN can be described as correct.
  • Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than 76.47% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.09. IPN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.52
Fwd PE 12.59
IPN.PA Price Earnings VS Forward Price EarningsIPN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPN indicates a rather cheap valuation: IPN is cheaper than 84.31% of the companies listed in the same industry.
  • 72.55% of the companies in the same industry are more expensive than IPN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.14
EV/EBITDA 8.07
IPN.PA Per share dataIPN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.57
PEG (5Y)1.77
EPS Next 2Y11.02%
EPS Next 3Y8.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. IPN.PA Dividend Analysis

5.1 Amount

  • IPN has a yearly dividend return of 0.98%, which is pretty low.
  • IPN's Dividend Yield is comparable with the industry average which is at 1.89.
  • Compared to an average S&P500 Dividend Yield of 1.81, IPN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

  • The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years2
Div Non Decr Years5
IPN.PA Yearly Dividends per shareIPN.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • IPN pays out 26.20% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP26.2%
EPS Next 2Y11.02%
EPS Next 3Y8.3%
IPN.PA Yearly Income VS Free CF VS DividendIPN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M
IPN.PA Dividend Payout.IPN.PA Dividend Payout, showing the Payout Ratio.IPN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IPN.PA Fundamentals: All Metrics, Ratios and Statistics

IPSEN

EPA:IPN (4/21/2026, 7:00:00 PM)

159.4

-3.1 (-1.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)07-29
Inst Owners15.91%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner ChangeN/A
Market Cap13.36B
Revenue(TTM)3.93B
Net Income(TTM)443.50M
Analysts71.58
Price Target162.27 (1.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP26.2%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.77%
PT rev (3m)23.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.75%
EPS NY rev (3m)14.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.69%
Revenue NY rev (3m)5.81%
Valuation
Industry RankSector Rank
PE 15.52
Fwd PE 12.59
P/S 3.4
P/FCF 16.14
P/OCF 11.55
P/B 3.08
P/tB 9.45
EV/EBITDA 8.07
EPS(TTM)10.27
EY6.44%
EPS(NY)12.66
Fwd EY7.94%
FCF(TTM)9.88
FCFY6.2%
OCF(TTM)13.8
OCFY8.66%
SpS46.88
BVpS51.74
TBVpS16.87
PEG (NY)1.57
PEG (5Y)1.77
Graham Number109.339 (-31.41%)
Profitability
Industry RankSector Rank
ROA 6.39%
ROE 10.23%
ROCE 17.79%
ROIC 13.93%
ROICexc 19.19%
ROICexgc 68.11%
OM 24.9%
PM (TTM) 11.29%
GM 80.89%
FCFM 21.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.88%
OM growth 5Y-1.79%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
F-Score7
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.17
Debt/EBITDA 0.58
Cap/Depr 52.58%
Cap/Sales 8.37%
Interest Coverage 250
Cash Conversion 72.13%
Profit Quality 186.67%
Current Ratio 1.96
Quick Ratio 1.79
Altman-Z 4.5
F-Score7
WACC7.98%
ROIC/WACC1.75
Cap/Depr(3y)123.84%
Cap/Depr(5y)123.25%
Cap/Sales(3y)11.93%
Cap/Sales(5y)11.8%
Profit Quality(3y)111.08%
Profit Quality(5y)104.31%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%9.65%
EPS Next Y9.87%
EPS Next 2Y11.02%
EPS Next 3Y8.3%
EPS Next 5Y6.81%
Revenue 1Y (TTM)9.92%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%1.83%
Revenue Next Year8.57%
Revenue Next 2Y9.28%
Revenue Next 3Y7.98%
Revenue Next 5Y6.47%
EBIT growth 1Y23.56%
EBIT growth 3Y3.4%
EBIT growth 5Y5.98%
EBIT Next Year35.29%
EBIT Next 3Y12.25%
EBIT Next 5Y10.42%
FCF growth 1Y522.48%
FCF growth 3Y4.75%
FCF growth 5Y5.6%
OCF growth 1Y26.34%
OCF growth 3Y5.92%
OCF growth 5Y8.44%

IPSEN / IPN.PA Fundamental Analysis FAQ

What is the fundamental rating for IPN stock?

ChartMill assigns a fundamental rating of 5 / 10 to IPN.PA.


What is the valuation status for IPN stock?

ChartMill assigns a valuation rating of 5 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.


What is the profitability of IPN stock?

IPSEN (IPN.PA) has a profitability rating of 5 / 10.


How financially healthy is IPSEN?

The financial health rating of IPSEN (IPN.PA) is 7 / 10.


Can you provide the expected EPS growth for IPN stock?

The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 9.87% in the next year.